Physician profile
Te-Ming Chang
NPI 1255326195
$846.89
in general payments reported to CMS, 2019-2025
14 companies · $20.23 in 2025
The $20.23 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $222 · 2021: $90.76 · 2022: $37.82 · 2023: $70.25 · 2024: $22.02 · 2025: $20.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $204.62 | 2020-2022 | |
| Smith+Nephew, INC. | $190.73 | 2019-2021 | |
| Innocoll Pharmaceuticals Limited | $54.98 | 2021 | |
| Medela LLC | $51.54 | 2019 | |
| Melinta Therapeutics, LLC | $50.11 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $47.30 | 2019 | |
| Lemaitre Vascular, INC. | $47.26 | 2019-2023 | Artegraft Vascular Graft |
| Aroa Biosurgery Incorporated | $45.82 | 2019 | |
| Ethicon US, LLC | $44.50 | 2021-2025 | Ethicon |
| Davol INC. | $32.40 | 2023 | Bard 3dmax Mesh |
| Allergan, INC. | $27.55 | 2019 | |
| Intuitive Surgical, INC. | $22.02 | 2024 | |
| Medtronic, INC. | $16.09 | 2023 | Signia |
| Teleflex LLC | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Te-Ming Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.